- Home
- MRNA vs ALB Comparison
MRNA vs ALB Comparison
Compare MRNA & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- ALB
- Stock Information
- Founded
- MRNA 2010
- ALB 1994
- Country
- MRNA United States
- ALB United States
- Employees
- MRNA N/A
- ALB N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- ALB Major Chemicals
- Sector
- MRNA Health Care
- ALB Industrials
- Exchange
- MRNA Nasdaq
- ALB Nasdaq
- Market Cap
- MRNA 9.8B
- ALB 10.3B
- IPO Year
- MRNA 2018
- ALB 1994
- Fundamental
- Price
- MRNA $27.89
- ALB $91.76
- Analyst Decision
- MRNA Hold
- ALB Hold
- Analyst Count
- MRNA 17
- ALB 16
- Target Price
- MRNA $42.40
- ALB $86.27
- AVG Volume (30 Days)
- MRNA 12.3M
- ALB 3.2M
- Earning Date
- MRNA 11-06-2025
- ALB 11-05-2025
- Dividend Yield
- MRNA N/A
- ALB 1.77%
- EPS Growth
- MRNA N/A
- ALB N/A
- EPS
- MRNA N/A
- ALB N/A
- Revenue
- MRNA $3,078,000,000.00
- ALB $4,993,278,000.00
- Revenue This Year
- MRNA N/A
- ALB N/A
- Revenue Next Year
- MRNA $9.75
- ALB $7.49
- P/E Ratio
- MRNA N/A
- ALB N/A
- Revenue Growth
- MRNA N/A
- ALB N/A
- 52 Week Low
- MRNA $23.15
- ALB $49.43
- 52 Week High
- MRNA $59.73
- ALB $113.91
- Technical
- Relative Strength Index (RSI)
- MRNA 58.77
- ALB 61.28
- Support Level
- MRNA $26.91
- ALB $79.30
- Resistance Level
- MRNA $28.99
- ALB $93.73
- Average True Range (ATR)
- MRNA 1.22
- ALB 4.38
- MACD
- MRNA 0.35
- ALB 0.72
- Stochastic Oscillator
- MRNA 76.78
- ALB 74.32
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.